VarMeter:一种用于预测糖基因变体影响的预测方法
Shiho Ohno1, Noriyoshi Manabe1, Tadashi Kaname2
1Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
Journal of human genetics
|July 8, 2025
概括
了解糖甘相关基因 (糖基因) 的遗传变异对于诊断罕见疾病至关重要. 像VarMeter2这样的新计算工具利用蛋白质结构预测来准确识别引起疾病的突变,帮助基因变异解释.
科学领域:
- 生物化学和分子生物学
- 遗传学和基因组学 遗传学和基因组学
- 结构生物学 结构生物学
背景情况:
- 葡萄糖对生理过程至关重要,与葡萄糖相关的基因 (葡萄糖基因) 的缺陷会导致葡萄糖酶化的先天性障碍.
- 目前对糖基因功能和疾病联系的理解受人类特异性作用和糖基因修饰的复杂性限制.
- 传统方法难以充分评估甘氨酸的多样性和复杂性,需要补充方法.
研究的目的:
- 通过结构信息,审查目前用于预测误解变量影响的方法.
- 介绍VarMeter和VarMeter2,用于预测致病变体的计算框架.
- 突出这些工具在揭示糖基因功能和疾病关联方面的有用性.
主要方法:
- 对人类遗传变异的系统评估,重点是错误的突变.
- 使用蛋白质结构预测工具,包括AlphaFold.
- 使用计算框架 (VarMeter,VarMeter2) 结合3D结构参数,pLDDT得分和Mahalanobis距离分析.
主要成果:
- 在ClinVar数据库中,VarMeter成功预测了致病变体.
- 通过整合AlphaFold pLDDT得分和Mahalanobis距离,VarMeter2显示了更好的预测准确性.
- 这些工具准确地预测了四种关键的甘氨酸相关蛋白质的致病变体.
结论:
- 基于结构的变异解释工具为了解糖基因功能和疾病提供了一种新的方法.
- VarMeter2增强了病原体变异的预测,有助于临床遗传变异解释.
- 这些进展有助于发现以前未知的糖基因功能及其与疾病相关性的发现.
相关概念视频
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genetic Variation
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...
Genes exist in different versions called alleles, which...


